The two health systems will help the genome center develop and administer the latest medicine for patients. Per the agreement, Hackensack Meridian Health’s Center for Discovery and Innovation and John Theurer Cancer Center will focus on exploring how genetics relate to behavioral disorders.
Researchers and clinicians at the Georgetown Lombardi Comprehensive Cancer Center will focus on how advanced genetic analysis can be better used to treat aggressive cancers.
“The Center for Discovery and Innovation is a key element of our mission to transform healthcare and lead toward the future,” said Robert Garret, CEO of Hackensack Meridian Health. “The John Theurer Cancer Center continues to provide the most advanced care currently available. Through our new partnerships at the New York Genome Center, patients in New Jersey and beyond will benefit from the latest technologies for personalized medicine.”
More articles on health IT:
Physician viewpoint: AI use might lead to overdiagnosis of cancer
6 skills ‘wise companies’ use to foster continuous innovation
Some ONC-certified EHRs present issues that could harm patient safety, analysis finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
